No Data
Terns Pharmaceuticals on the Brink of Innovation With Upcoming TERN-701 Data Release
Top 3 Health Care Stocks You'll Regret Missing In Q4
Press Release: Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
Express News | Terns Pharmaceuticals Appoints Heather Turner, J.d., to Board of Directors
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth